Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
18.16
-0.36 (-1.97%)
Sep 15, 2026, 9:55 AM EDT - Market open
Dyne Therapeutics Market Cap
Dyne Therapeutics has a market cap or net worth of $3.39 billion as of September 15, 2026. Its market cap has increased by 81.23% in one year.
Market Cap
3.39B
Enterprise Value
2.73B
1-Year Change
81.23%
Ranking
Category
Stock Price
$18.16
ChartMarket Cap Chart
Since the IPO on September 17, 2020, Dyne Therapeutics's market cap has increased from $790.90M to $3.39B, an increase of 328.68%. That is a compound annual growth rate of 27.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 3.39B | 5.27% |
| Dec 31, 2025 | 3.22B | 34.33% |
| Dec 31, 2024 | 2.40B | 193.72% |
| Dec 29, 2023 | 816.30M | 35.12% |
| Dec 30, 2022 | 604.12M | -0.31% |
| Dec 31, 2021 | 606.03M | -36.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Enliven Therapeutics | 3.98B |
| Iovance Biotherapeutics | 3.90B |
| Viking Therapeutics | 3.73B |
| IDEAYA Biosciences | 3.63B |
| Legend Biotech | 3.61B |
| AbCellera Biologics | 3.53B |
| Tarsus Pharmaceuticals | 3.48B |
| Denali Therapeutics | 3.37B |